{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:03:02Z","timestamp":1782831782743,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00296-014-3204-y","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T13:26:42Z","timestamp":1419859602000},"page":"911-913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cat scratch disease during infliximab therapy: a case report and literature review"],"prefix":"10.1007","volume":"35","author":[{"given":"Yi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"3204_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/187153009789044347","volume":"9","author":"MW Wiedmann","year":"2009","unstructured":"Wiedmann MW, M\u00f6ssner J et al (2009) TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases. Endocr Metab Immune Disord Drug Targets 9:295\u2013314","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"3204_CR2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/thoraxjnl-2012-202974","volume":"68","author":"RW Hofland","year":"2013","unstructured":"Hofland RW, Thijsen SF et al (2013) Tuberculosis during TNF-\u03b1 inhibitor therapy, despite screening. Thorax 68:1079\u20131080","journal-title":"Thorax"},{"key":"3204_CR3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/rheumatology\/kep241","volume":"48","author":"A Schiffmann","year":"2009","unstructured":"Schiffmann A, Pers YM, Lukas C et al (2009) Mesenteric and splenic cat-scratch disease during etanercept therapy. Rheumatology 48:1461\u20131462","journal-title":"Rheumatology"},{"key":"3204_CR4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jbspin.2006.05.017","volume":"74","author":"S Mathieu","year":"2007","unstructured":"Mathieu S, Vellin JF, Poujol D et al (2007) Cat scratch disease during etanercept therapy. Joint Bone Spine 74:184\u2013186","journal-title":"Joint Bone Spine"},{"issue":"3","key":"3204_CR5","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1111\/j.1365-4632.2012.05679.x","volume":"53","author":"F Osorio","year":"2014","unstructured":"Osorio F, Pedrosa A, Azevedo F et al (2014) Cat scratch disease during anti-tumor necrosis factor-alpha therapy: case report and review of literature. Int J Dermatol 53(3):e182\u2013e183","journal-title":"Int J Dermatol"},{"issue":"3","key":"3204_CR6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.idc.2005.06.001","volume":"19","author":"F Massei","year":"2005","unstructured":"Massei F, Gori L, Macchia P et al (2005) The expanded spectrum of bartonellosis in children. Infect Dis Clin North Am 19(3):691\u2013711","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"3204_CR7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archinte.1986.00360140238035","volume":"146","author":"JR Black","year":"1986","unstructured":"Black JR, Herrington DA (1986) Life-threatening cat-scratch disease in an immunocompromised host. Arch Intern Med 146(2):394\u2013396","journal-title":"Arch Intern Med"},{"key":"3204_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/imt.13.10","volume":"5","author":"A Jain","year":"2013","unstructured":"Jain A, Sinqn JA (2013) Harms of tumor necrosis factor inhibitors in rheumatic diseases: a focused systematic review of the literature. Immunotherapy 5:265\u2013299","journal-title":"Immunotherapy"},{"key":"3204_CR9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.62.9.829","volume":"62","author":"D Baeten","year":"2003","unstructured":"Baeten D, Kruithof E, Van den Bosch F et al (2003) Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defense in the pathogenesis of the disease? Ann Rheum Dis 62:829\u2013834","journal-title":"Ann Rheum Dis"},{"key":"3204_CR10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY et al (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261\u20131265","journal-title":"Clin Infect Dis"},{"issue":"11","key":"3204_CR11","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archpedi.1985.02140130062031","volume":"139","author":"HA Carithers","year":"1985","unstructured":"Carithers HA (1985) Cat-scratch disease. An overview based on a study of 1,200 patients. Am J Dis Child 139(11):1124\u20131133","journal-title":"Am J Dis Child"},{"key":"3204_CR12","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1128\/AAC.48.6.1921-1933.2004","volume":"48","author":"JM Rolain","year":"2004","unstructured":"Rolain JM, Brouqui P, Koehler JE et al (2004) Recommendations for treatment of human infections caused by bartonella species. Antimicrob Agents Chemother 48:1921\u20131933","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3204-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3204-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3204-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:28:28Z","timestamp":1559042908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3204-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,30]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3204-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,30]]}}}